RCVS: The Rational Approach to Diagnosis and Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).
Epistemonikos ID: c023c139f5db0cca2b503174c4b3e066f362f4f6
First added on: May 20, 2024